Your browser doesn't support javascript.
loading
Outcome of Hydroxyurea Use in SCD and Evaluation of Patients' Perception and Experience in Nigeria.
Chianumba, Reuben Ikechukwu; Ofakunrin, Akinyemi O D; Morrice, Jack; Olanrewaju, Olaniyi; Oniyangi, Oluseyi; Kuliya-Gwarzo, Aisha; Nnebe-Agumadu, Uche; Isa, Hezekiah Alkali; Nnodu, Obiageli Eunice.
Afiliação
  • Chianumba RI; Centre of Excellence for Sickle Cell Disease Research and Training, University of Abuja, Abuja, Nigeria.
  • Ofakunrin AOD; Department of Paediatrics, Jos University Teaching Hospital, Jos, Nigeria.
  • Morrice J; Division of Human Genetics, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
  • Olanrewaju O; Irua Specialist Teaching Hospital, Irrua, Nigeria.
  • Oniyangi O; Department of Paediatrics, National Hospital, Abuja, Nigeria.
  • Kuliya-Gwarzo A; Bayero University Kano/Aminu Kano University Teaching Hospital, Kano, Nigeria.
  • Nnebe-Agumadu U; Department of Paediatrics, University of Abuja Teaching Hospital, Gwagwalada, Nigeria.
  • Isa HA; Centre of Excellence for Sickle Cell Disease Research and Training, University of Abuja, Abuja, Nigeria.
  • Nnodu OE; Department of Haematology and Blood Transfusion, College of Health Sciences, University of Abuja, Abuja, Nigeria.
Front Genet ; 13: 826132, 2022.
Article em En | MEDLINE | ID: mdl-35401653

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article